[{"question": "Which of the following enzymes does NOT participate in beta-oxidation of fatty acids ?:", "correct_answer": "Peroxidase", "correct_idx": 1, "options": ["A)Thiolase", "B)Peroxidase", "C)Enoil hydratase", "D)Acyl dehydrogenase."], "prompt": "Which of the following enzymes does NOT participate in beta-oxidation of fatty acids ?:A)Thiolase\nB)Peroxidase\nC)Enoil hydratase\nD)Acyl dehydrogenase.", "subject_name": "chemistry", "output0": "Thiolase is not involved in the beta-oxidation of fatty acids. Instead, it is involved in the synthesis of amino acids from alpha-keto acids.\n\n", "output1": "Peroxidase does not participate in beta-oxidation of fatty acids. The enzymes that do participate in beta-oxidation are thiolase, enoyl hydratase, and acyl dehydrogenase.\n\n", "output2": "Enoil hydratase does not participate in the beta-oxidation of fatty acids. Beta-oxidation is the process by which fatty acids are broken down into smaller molecules. The enzymes that participate in this process are thiolase, peroxidase, and acyl dehydrogenase.\n\n", "output3": "Acyl dehydrogenase is an enzyme that catalyzes the dehydrogenation of fatty acids, but it does not participate in the beta-oxidation of fatty acids. The other enzymes mentioned, thiolase, peroxidase, and enoyl hydratase, are all involved in the beta-oxidation process.\n\n"}, {"question": "Which of the following is not a scholar Jonsen content such as Face Using clinical cases to solve the problem Four themes law or four quadrants (four topics or four boxes method) of?", "correct_answer": "Do no harm principle (nonmaleficience)", "correct_idx": 0, "options": ["A)Do no harm principle (nonmaleficience)", "B)Medical indications (medical indications)", "C)Face preferences disease (patient preferences)", "D)\u2f63 living quality (quality of life)"], "prompt": "Which of the following is not a scholar Jonsen content such as Face Using clinical cases to solve the problem Four themes law or four quadrants (four topics or four boxes method) of?A)Do no harm principle (nonmaleficience)\nB)Medical indications (medical indications)\nC)Face preferences disease (patient preferences)\nD)\u2f63 living quality (quality of life)", "subject_name": null, "output0": "The Do no harm principle (nonmaleficience) is not a scholar Jonsen content, it is a principle that is commonly used in medical ethics and is not directly related to the four themes or quadrants of Jonsen's work.\n\n", "output1": "Medical indications are not considered a scholar Jonsen content. Jonsen's content focuses on the ethical principles and values that guide clinical decision-making, not the medical indications for a particular treatment.\n\n", "output2": "Patient preferences are not one of the four themes of the Jonsen content. The four themes of the Jonsen content are: Do no harm principle (nonmaleficience), Medical indications (medical indications), \u2f63 living quality (quality of life), and Face using clinical cases to solve the problem (case-based reasoning).\n\n", "output3": "The four themes or four quadrants method is a tool used to help healthcare professionals consider the ethical principles of autonomy, beneficence, nonmaleficence, and justice when making decisions about patient care. These themes are not the same as the quality of life, which is a broader concept that encompasses the patient's overall well-being and satisfaction with their care.\n\n"}, {"question": "A glycopeptide antibiotic requires avoiding the formation of foam in its reconstitution, or letting it rest for 15 minutes before extracting the contents of the vial. Is about:", "correct_answer": "Teicoplanin", "correct_idx": 0, "options": ["A)Teicoplanin", "B)Gentamicin", "C)Cefalotina.", "D)Piperacillin"], "prompt": "A glycopeptide antibiotic requires avoiding the formation of foam in its reconstitution, or letting it rest for 15 minutes before extracting the contents of the vial. Is about:A)Teicoplanin\nB)Gentamicin\nC)Cefalotina.\nD)Piperacillin", "subject_name": "nursery", "output0": "Teicoplanin is a glycopeptide antibiotic that is prone to forming foam during reconstitution. Therefore, it is important to avoid foam formation by letting the reconstituted solution rest for 15 minutes before extracting the contents of the vial.\n\n", "output1": "Gentamicin is a glycopeptide antibiotic that is prone to forming foam during reconstitution. To avoid this, it is recommended to let the vial rest for 15 minutes before extracting the contents. This allows the powder to dissolve fully and prevents the formation of foam.\n\n", "output2": "Cefalotin is a glycopeptide antibiotic that requires avoiding the formation of foam in its reconstitution. This is because the foam can prevent the proper mixing of the antibiotic and can lead to ineffective or uneven dosing. Therefore, it is recommended to let the vial rest for 15 minutes before extracting the contents to allow for proper mixing and to avoid foam formation.\n\n", "output3": "Piperacillin is a glycopeptide antibiotic that is prone to forming foam during reconstitution. To avoid this, it is recommended to let the vial rest for 15 minutes before extracting the contents. Teicoplanin, gentamicin, and cefalotin are not known to form foam during reconstitution.\n\n"}, {"question": "28 year old woman, appeared hirsutism, hoarseness, and menstrual flow and other symptoms, abdominal ultrasound examination revealed ovarian cancer, the most likely diagnosis is:", "correct_answer": "Suote Li - Laiting cell tumor (Sertoli-Leydig cell tumor)", "correct_idx": 2, "options": ["A)Granulosa cell tumor (granulosa cell tumor)", "B)Follicular tumor cells membrane (thecoma)", "C)Suote Li - Laiting cell tumor (Sertoli-Leydig cell tumor)", "D)Brenner's tumor (Brenner tumor)"], "prompt": "28 year old woman, appeared hirsutism, hoarseness, and menstrual flow and other symptoms, abdominal ultrasound examination revealed ovarian cancer, the most likely diagnosis is:A)Granulosa cell tumor (granulosa cell tumor)\nB)Follicular tumor cells membrane (thecoma)\nC)Suote Li - Laiting cell tumor (Sertoli-Leydig cell tumor)\nD)Brenner's tumor (Brenner tumor)", "subject_name": null, "output0": "The most likely diagnosis is granulosa cell tumor based on the symptoms of hirsutism, hoarseness, and menstrual irregularities, as well as the abdominal ultrasound findings. These symptoms are consistent with the presence of a granulosa cell tumor, which is a type of ovarian cancer that arises from the granulosa cells of the ovary.\n\n", "output1": "The most likely diagnosis for a 28-year-old woman with hirsutism, hoarseness, and menstrual irregularity, along with abdominal ultrasound findings of ovarian cancer, is a follicular tumor cells membrane (thecoma). This tumor is the most common type of ovarian cancer in young women.\n\n", "output2": "The symptoms you described, such as hirsutism, hoarseness, and menstrual irregularities, are consistent with a tumor that arises from the sex cord-stromal cells of the ovary, specifically the Sertoli-Leydig cells. The abdominal ultrasound examination also supports this diagnosis.\n\n", "output3": "The symptoms described, such as hirsutism, hoarseness, and menstrual irregularities, are consistent with a Brenner's tumor. Additionally, the abdominal ultrasound examination findings are also consistent with this diagnosis.\n\n"}, {"question": "Fill the missing data in the common risk factor approach diagram.", "correct_answer": "Diet and smoking", "correct_idx": 0, "options": ["A)Diet and smoking", "B)Smoking and disease", "C)Smoking and prevention", "D)Prevention and diet"], "prompt": "Fill the missing data in the common risk factor approach diagram.A)Diet and smoking\nB)Smoking and disease\nC)Smoking and prevention\nD)Prevention and diet", "subject_name": "Dental", "output0": "The common risk factor approach is a framework for understanding the relationship between different risk factors and disease. In this approach, diet and smoking are two of the key risk factors that contribute to the development of chronic diseases. By addressing these risk factors, it is possible to prevent or reduce the risk of developing these diseases.\n\n", "output1": "The common risk factor approach is a public health strategy that focuses on the shared risk factors for multiple diseases. In this case, the shared risk factor is smoking. Smoking is a major risk factor for many diseases, including heart disease, cancer, and respiratory diseases.\n\n", "output2": "Smoking is a major risk factor for many diseases, such as lung cancer, heart disease, and stroke. By preventing smoking, individuals can reduce their risk of developing these diseases.\n\n", "output3": "The Common Risk Factor Approach diagram shows the relationship between smoking and various diseases, as well as the potential for prevention and healthy eating habits. By addressing both smoking and diet, individuals can reduce their risk of developing these diseases. Therefore, the correct answer is D)Prevention and diet.\n\n"}, {"question": "A 24-year-old man comes to the physician because of a painful swelling above his buttocks for 1 week. He is unable to sit for extended periods because of the pain. He has obstructive sleep apnea and type 2 diabetes mellitus. His only medication is metformin. He appears anxious. He is 175 cm (5 ft 9 in) tall and weighs 114 kg (251 lb); BMI is 37 kg/m2. His temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 96/min and blood pressure is 124/86 mm Hg. Examination shows facial acne. A cyst is seen above the natal cleft. There is tenderness to palpation at the cyst and surrounding tissue. The skin around the cyst is warm and erythematous. Which of the following is the most appropriate next step in management?", "correct_answer": "Incision and drainage", "correct_idx": 1, "options": ["A)Coccygectomy", "B)Incision and drainage", "C)Retinoid therapy", "D)Surgical resection and primary wound closure"], "prompt": "A 24-year-old man comes to the physician because of a painful swelling above his buttocks for 1 week. He is unable to sit for extended periods because of the pain. He has obstructive sleep apnea and type 2 diabetes mellitus. His only medication is metformin. He appears anxious. He is 175 cm (5 ft 9 in) tall and weighs 114 kg (251 lb); BMI is 37 kg/m2. His temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 96/min and blood pressure is 124/86 mm Hg. Examination shows facial acne. A cyst is seen above the natal cleft. There is tenderness to palpation at the cyst and surrounding tissue. The skin around the cyst is warm and erythematous. Which of the following is the most appropriate next step in management?A)Coccygectomy\nB)Incision and drainage\nC)Retinoid therapy\nD)Surgical resection and primary wound closure", "subject_name": null, "output0": "Coccygectomy is the most appropriate next step in management for this patient's condition. This is because the cyst is located near the natal cleft, which is a common site for cysts to form in this age group. Additionally, the patient's history of obstructive sleep apnea and type 2 diabetes mellitus increases the risk of complications from a cyst that is left untreated. Coccygectomy is a surgical procedure that involves removing the cyst and any surrounding infected tissue. It is a relatively simple procedure that can be performed under local anesthesia and has a low risk of complications.\n\n", "output1": "The most appropriate next step in management for this patient with a cyst above the natal cleft would be incision and drainage. This is because the patient is experiencing pain and tenderness, and the cyst is warm and erythematous, indicating an infected cyst. Additionally, the patient's age and medical history suggest that a more conservative approach is appropriate. Coccygectomy, retinoid therapy, and surgical resection and primary wound closure are not the most appropriate next steps in this case.\n\n", "output2": "Retinoid therapy is the most appropriate next step in management because it is a non-surgical approach that can help reduce the size of the cyst and prevent complications. Additionally, retinoid therapy can help improve the patient's acne and reduce the risk of infection.\n\n", "output3": "The most appropriate next step in management is surgical resection and primary wound closure. The patient's symptoms and examination findings suggest a diagnosis of a cystic tumor, which is a common condition in this age group. The cyst is causing pain and discomfort, and the patient is unable to sit for extended periods. The patient's obstructive sleep apnea and type 2 diabetes mellitus increase the risk of complications from the cyst. Surgical resection and primary wound closure is the most appropriate next step to treat the cyst and alleviate the patient's symptoms.\n\n"}, {"question": "Acetazolamide is given to a patient of angle closure glaucoma. It is a non- competitive inhibitor of carbonic anhydrase enzyme. Which of the following should be the effect of this drug?", "correct_answer": "Decrease in Vmax", "correct_idx": 0, "options": ["A)Decrease in Vmax", "B)Decrease in Km", "C)Decrease in both Km and Vmax", "D)No change in Vmax"], "prompt": "Acetazolamide is given to a patient of angle closure glaucoma. It is a non- competitive inhibitor of carbonic anhydrase enzyme. Which of the following should be the effect of this drug?A)Decrease in Vmax\nB)Decrease in Km\nC)Decrease in both Km and Vmax\nD)No change in Vmax", "subject_name": "Pharmacology", "output0": "Acetazolamide is a non-competitive inhibitor of carbonic anhydrase enzyme, which is involved in the transport of hydrogen ions and carbon dioxide in the eye. By inhibiting this enzyme, acetazolamide decreases the production of hydrogen ions, which in turn decreases the intraocular pressure (IOP) and helps to relieve the symptoms of angle closure glaucoma. This effect is primarily due to a decrease in the maximum velocity of the enzyme (Vmax), rather than a change in the Michaelis constant (Km).\n\n", "output1": "Acetazolamide is a non-competitive inhibitor of carbonic anhydrase enzyme, which means it binds to the enzyme in a non-competitive manner, altering the enzyme's active site. This results in a decrease in the enzyme's Km value, but not in its Vmax value.\n\n", "output2": "Acetazolamide is a non-competitive inhibitor of carbonic anhydrase, which means it binds to the enzyme in a non-competitive manner, altering its conformation and activity. This results in a decrease in both the maximum velocity (Vmax) and the Michaelis constant (Km) of the enzyme, leading to a decrease in the rate of the reaction.\n\n", "output3": "Acetazolamide is a non-competitive inhibitor of carbonic anhydrase enzyme, which means it binds to a site on the enzyme that is not involved in the active site. As a result, the drug does not affect the Vmax of the enzyme, but rather the Km (the Michaelis constant).\n\n"}, {"question": "Traumatic optic neuropathy due to closed head trauma commonly affects which pa of optic nerve -", "correct_answer": "Optic canal", "correct_idx": 0, "options": ["A)Optic canal", "B)Intra ocular pa", "C)Intracranial pa", "D)Optic tract"], "prompt": "Traumatic optic neuropathy due to closed head trauma commonly affects which pa of optic nerve -A)Optic canal\nB)Intra ocular pa\nC)Intracranial pa\nD)Optic tract", "subject_name": "Surgery", "output0": "The optic canal is a narrow passageway that the optic nerve passes through in the skull. Traumatic optic neuropathy due to closed head trauma can cause damage to the optic nerve as it passes through the optic canal, leading to vision loss.\n\n", "output1": "The intraocular part of the optic nerve is the most commonly affected area in traumatic optic neuropathy due to closed head trauma. This is because the intraocular part of the optic nerve is relatively avascular, which makes it more susceptible to injury.\n\n", "output2": "Traumatic optic neuropathy due to closed head trauma commonly affects the intracranial part of the optic nerve, which is the portion of the nerve that is located within the skull. This is because the intracranial part of the nerve is more susceptible to damage from the forces of the trauma.\n\n", "output3": "Traumatic optic neuropathy due to closed head trauma commonly affects the optic tract, which is responsible for transmitting visual information from the eye to the brain. Damage to the optic tract can result in vision loss or blindness.\n\n"}, {"question": "First line treatment of infeility in PCOS is ?", "correct_answer": "Clomiphene", "correct_idx": 0, "options": ["A)Clomiphene", "B)FSH", "C)GnRH", "D)Assisted reproductive techniques"], "prompt": "First line treatment of infeility in PCOS is ?A)Clomiphene\nB)FSH\nC)GnRH\nD)Assisted reproductive techniques", "subject_name": "Gynaecology & Obstetrics", "output0": "Clomiphene is the first-line treatment for infertility in Polycystic Ovary Syndrome (PCOS). It is an oral medication that stimulates ovulation and is usually effective in restoring menstrual cycles and improving fertility in women with PCOS.\n\n", "output1": "FSH (follicle-stimulating hormone) is the first-line treatment for infertility in PCOS (polycystic ovary syndrome). It works by stimulating the ovary to produce eggs and can help improve ovulation and fertility.\n\n", "output2": "GnRH is the first-line treatment for infertility in PCOS. It is a hormone that stimulates the production of follicles and can help increase the chances of ovulation.\n\n", "output3": "The first line treatment of infertility in PCOS is often assisted reproductive techniques such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). This is because PCOS is a leading cause of infertility, and these techniques can help improve the chances of conception.\n\n"}, {"question": "Hepatic First pass metabolism will be bypassed by the foltowing routes of drug adminisration excePt?", "correct_answer": "Oral", "correct_idx": 0, "options": ["A)Oral", "B)Intravenous", "C)Sublingual", "D)Intradermal"], "prompt": "Hepatic First pass metabolism will be bypassed by the foltowing routes of drug adminisration excePt?A)Oral\nB)Intravenous\nC)Sublingual\nD)Intradermal", "subject_name": "Pharmacology", "output0": "Hepatic first-pass metabolism refers to the metabolism of drugs in the liver before they reach the systemic circulation. When drugs are administered orally, they must pass through the liver before they can reach the systemic circulation. Therefore, oral administration is not a viable option for bypassing hepatic first-pass metabolism. In contrast, intravenous administration is an option that can bypass the liver and deliver the drug directly to the systemic circulation, thereby avoiding first-pass metabolism.\n\n", "output1": "Intravenous administration bypasses the liver, therefore, the drug is not subject to hepatic first-pass metabolism.\n\n", "output2": "Sublingual administration of drugs bypasses the liver and therefore the first-pass metabolism, which is the metabolism that occurs in the liver before the drug reaches the systemic circulation. This can result in higher bioavailability and more rapid onset of action compared to other routes of administration.\n\n", "output3": "Intradermal administration bypasses the liver and the first-pass metabolism, allowing the drug to be absorbed directly into the bloodstream.\n\n"}]